Literature DB >> 10521532

Conserved domains of glycosyltransferases.

D Kapitonov1, R K Yu.   

Abstract

Glycosyltransferases catalyze the synthesis of glycoconjugates by transferring a properly activated sugar residue to an appropriate acceptor molecule or aglycone for chain initiation and elongation. The acceptor can be a lipid, a protein, a heterocyclic compound, or another carbohydrate residue. A catalytic reaction is believed to involve the recognition of both the donor and acceptor by suitable domains, as well as the catalytic site of the enzyme. To elucidate the structural requirements for substrate recognition and catalytic reactions of glycosyltransferases, we have searched the databases for homologous sequences, identified conserved amino acid residues, and proposed potential domain motifs for these enzymes. Depending on the configuration of the anomeric functional group of the glycosyl donor molecule and of the resulting glycoconjugate, all known glycosyltransferases can be divided into two major types: retaining glycosyltransferases, which transfer sugar residue with the retention of anomeric configuration, and inverting glycosyltransferases, which transfer sugar residue with the inversion of anomeric configuration. One conserved domain of the inverting glycosyltransferases identified in the database is responsible for the recognition of a pyrimidine nucleotide, which is either the UDP or the TDP portion of a donor sugar-nucleotide molecule. This domain is termed "Nucleotide Recognition Domain 1 beta," or NRD1 beta, since the type of nucleotide is the only common structure among the sugar donors and acceptors. NRD1 beta is present in 140 glycosyltransferases. The central portion of the NRD1 beta domain is very similar to the domain that is present in one family of retaining glycosyltransferases. This family is termed NRD1 alpha to designate the similarity and stereochemistry of sugar transfer, and it consists of 77 glycosyltransferases identified thus far. In the central portion there is a homologous region for these two families and this region probably has a catalytic function. A third conserved domain is found exclusively in membrane-bound glycosyltransferases and is termed NRD2; this domain is present in 98 glycosyltransferases. All three identified NRDs are present in archaebacterial, eubacterial, viral, and eukaryotic glycosyltransferases. The present article presents the alignment of conserved NRD domains and also presents a brief overview of the analyzed glycosyltransferases which comprise about 65% of all known sugar-nucleotide dependent (Leloir-type) and putative glycosyltransferases in different databases. A potential mechanism for the catalytic reaction is also proposed. This proposed mechanism should facilitate the design of experiments to elucidate the regulatory mechanisms of glycosylation reactions. Amino acid sequence information within the conserved domain may be utilized to design degenerate primers for identifying DNA encoding new glycosyltransferases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521532     DOI: 10.1093/glycob/9.10.961

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  36 in total

1.  The 1.9 A crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis.

Authors:  S Ha; D Walker; Y Shi; S Walker
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

2.  Molecular discrimination between Neisseria meningitidis serogroups W-135 and Y based on the nucleotide recognition domain sequence of the capsule polymerases.

Authors:  Heike Claus; Wataru Matsunaga; Ulrich Vogel
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

3.  Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.

Authors:  E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Khushi L Matta; Sriram Neelamegham
Journal:  Biochemistry       Date:  2007-12-08       Impact factor: 3.162

4.  Biochemical and biophysical characterization of the sialyl-/hexosyltransferase synthesizing the meningococcal serogroup W135 heteropolysaccharide capsule.

Authors:  Angela Romanow; Thomas Haselhorst; Katharina Stummeyer; Heike Claus; Andrea Bethe; Martina Mühlenhoff; Ulrich Vogel; Mark von Itzstein; Rita Gerardy-Schahn
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

5.  Role of PelF in pel polysaccharide biosynthesis in Pseudomonas aeruginosa.

Authors:  Aamir Ghafoor; Zoe Jordens; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2013-02-22       Impact factor: 4.792

Review 6.  Insect chitin synthases: a review.

Authors:  Hans Merzendorfer
Journal:  J Comp Physiol B       Date:  2005-08-02       Impact factor: 2.200

7.  Crystal structure of the MurG:UDP-GlcNAc complex reveals common structural principles of a superfamily of glycosyltransferases.

Authors:  Yanan Hu; Lan Chen; Sha Ha; Ben Gross; Brian Falcone; Deborah Walker; Maryam Mokhtarzadeh; Suzanne Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

8.  Dependence of stress resistance on a spore coat heteropolysaccharide in Dictyostelium.

Authors:  Christopher M West; Phuong Nguyen; Hanke van der Wel; Talibah Metcalf; Kristin R Sweeney; Ira J Blader; Gregory W Erdos
Journal:  Eukaryot Cell       Date:  2008-11-07

9.  Identification and analysis of novel functional sites in human GD3-synthase.

Authors:  Yihua Gu; Robert K Yu
Journal:  Biochem Biophys Res Commun       Date:  2008-03-17       Impact factor: 3.575

10.  Biochemical characterization and membrane topology of Alg2 from Saccharomyces cerevisiae as a bifunctional alpha1,3- and 1,6-mannosyltransferase involved in lipid-linked oligosaccharide biosynthesis.

Authors:  Michael Kämpf; Birgit Absmanner; Markus Schwarz; Ludwig Lehle
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.